Understanding the Factors Affecting Transdermal Drug Delivery System Success
•
4 min read
The first FDA-approved transdermal patch for motion sickness was released in 1979, marking the beginning of a now multibillion-dollar industry. The effectiveness of this non-invasive method hinges on many variables, and understanding the factors affecting transdermal drug delivery system (TDDS) success is crucial for both drug developers and patients. These factors are complex, interacting biological, chemical, and physical elements that influence how a medication permeates the skin's protective barrier and enters the bloodstream.
